Norton Rose Fulbright Canada LLP
Related services and key industries
Key industry sectors
Jonathan Chong practises in intellectual property, with a focus on patent litigation. He has appeared before the Federal Court at the trial of a patent infringement action and for the hearing of an application made pursuant to the Patented Medicines (Notice of Compliance) Regulations (PMNOC Regulations).
Dr. Chong's litigation experience involves medical devices and pharmaceutical products, including small molecule, peptide, monoclonal antibody and vaccine products. These matters pertain to patents covering compounds, salts, crystal forms, formulations and treatment of medical conditions. He has been involved in patent infringement and impeachment actions, and proceedings instituted pursuant to the old and the new PMNOC Regulations.
Dr. Chong's graduate research involved the synthesis and study of porous metal-organic materials. He worked at the National Research Council of Canada and developed green chemical processes and materials derived from renewable resources. His research has been published in leading scientific journals.
Prior to joining our Montréal office, Dr. Chong articled and summered with a leading international law firm specializing in intellectual property.
B.Sc.(Hons.), Biochemistry and Chemistry, University of British Columbia, 2002
- Quebec 2017
- Ontario 2016
- Canadian Bar Association
- Intellectual Property Institute of Canada
- Young Bar of Montreal
IP monitor - A tearful conundrum: Canada's FCA affirms dismissal of infringement claim in patent suit regarding ophthalmic medical devices
Publication | July 09, 2019
Publication | May 2019
Publication | March 21, 2019
IP monitor - Cry me a river: plaintiffs’ proposed claim construction leads to invalidation of asserted claims by the Gillette defence
Publication | March 2018